212 related articles for article (PubMed ID: 25655028)
1. The role of platelet-activating factor in mesangial pathophysiology.
Reznichenko A; Korstanje R
Am J Pathol; 2015 Apr; 185(4):888-96. PubMed ID: 25655028
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.
Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z
J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665
[TBL] [Abstract][Full Text] [Related]
3. Mesangial pathology in glomerular disease: targets for therapeutic intervention.
Scindia YM; Deshmukh US; Bagavant H
Adv Drug Deliv Rev; 2010 Nov; 62(14):1337-43. PubMed ID: 20828589
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes.
Coppo R; Fonsato V; Balegno S; Ricotti E; Loiacono E; Camilla R; Peruzzi L; Amore A; Bussolati B; Camussi G
Kidney Int; 2010 Mar; 77(5):417-27. PubMed ID: 20016469
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis.
Iso-O N; Noto H; Hara M; Togo M; Karasawa K; Ohashi N; Noiri E; Hashimoto Y; Kadowaki T; Kimura S; Watanabe T; Tsukamoto K
Mol Ther; 2006 Jan; 13(1):118-26. PubMed ID: 16213192
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.
Tsoupras AB; Fragopoulou E; Nomikos T; Iatrou C; Antonopoulou S; Demopoulos CA
Mediators Inflamm; 2007; 2007():27683. PubMed ID: 17710109
[TBL] [Abstract][Full Text] [Related]
7. Plasticity of mesangial cells: a basis for understanding pathological alterations.
Herrera GA
Ultrastruct Pathol; 2006; 30(6):471-9. PubMed ID: 17182440
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes.
Bussolati B; Mariano F; Migliori M; Camussi G
Kidney Int; 2002 Oct; 62(4):1322-31. PubMed ID: 12234302
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism.
Tsantila N; Tsoupras AB; Fragopoulou E; Antonopoulou S; Iatrou C; Demopoulos CA
Angiology; 2011 Apr; 62(3):209-18. PubMed ID: 20805097
[TBL] [Abstract][Full Text] [Related]
10. Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.
Fragopoulou E; Iatrou C; Demopoulos CA
Mediators Inflamm; 2005 Oct; 2005(5):263-72. PubMed ID: 16258193
[TBL] [Abstract][Full Text] [Related]
11. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?
Tsoupras AB; Chini M; Tsogas N; Fragopoulou E; Nomikos T; Lioni A; Mangafas N; Demopoulos CA; Antonopoulou S; Lazanas MC
AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1079-86. PubMed ID: 18620493
[TBL] [Abstract][Full Text] [Related]
12. The role of platelet-activating factor (PAF) in experimental glomerular injury.
Ortiz A; Gomez-Chiarri M; Lerma JL; Gonzalez E; Egido J
Lipids; 1991 Dec; 26(12):1310-5. PubMed ID: 1819722
[TBL] [Abstract][Full Text] [Related]
13. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
Perico N; Delaini F; Tagliaferri M; Abbate M; Cucchi M; Bertani T; Remuzzi G
Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.
Bussolati B; Mariano F; Biancone L; Foà R; David S; Cambi V; Camussi G
Am J Pathol; 1999 Feb; 154(2):623-32. PubMed ID: 10027419
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytokines and platelet-activating factor in renal pathology.
Camussi G; Tetta C; Bussolino F; Andres G; Turello E; Baglioni C
J Lipid Mediat; 1990; 2 Suppl():S203-13. PubMed ID: 2133283
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells.
Kester M; Thomas CP; Wang J; Dunn MJ
J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121
[TBL] [Abstract][Full Text] [Related]
17. Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells.
Schlondorff D; Satriano JA; Hagege J; Perez J; Baud L
J Clin Invest; 1984 Apr; 73(4):1227-31. PubMed ID: 6423667
[TBL] [Abstract][Full Text] [Related]
18. [The role of the platelet-activating factor (PAF-acether) in renal pathology].
Pirotzky E; Braquet P
Presse Med; 1988 Apr; 17(14):692-5. PubMed ID: 2966954
[TBL] [Abstract][Full Text] [Related]
19. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM
Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor induces cell growth through tyrosine phosphorylation pathway in cultured rat mesangial cells.
Komatsu H; Ishiwari K; Shikata A; Nishida M; Kawakatsu H; Sawada T
Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):622-31. PubMed ID: 8583698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
